• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弗里德里希共济失调症中神经元的线粒体功能障碍。

Mitochondrial dysfunction in neurons in Friedreich's ataxia.

机构信息

Department of Pediatrics, Columbia University Medical Center, New York, NY, United States of America.

Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, United States of America.

出版信息

Mol Cell Neurosci. 2020 Jan;102:103419. doi: 10.1016/j.mcn.2019.103419. Epub 2019 Nov 23.

DOI:10.1016/j.mcn.2019.103419
PMID:31770591
Abstract

Friedreich's ataxia is a multisystemic genetic disorder within the family of mitochondrial diseases that is characterized by reduced levels of the essential mitochondrial protein frataxin. Based on clinical evidence, the peripheral nervous system is affected early, neuronal dysfunction progresses towards the central nervous system, and other organs (such as heart and pancreas) are affected later. However, little attention has been given to the specific aspects of mitochondria function altered by frataxin depletion in the nervous system. For years, commonly accepted views on mitochondria dysfunction in Friedreich's ataxia stemmed from studies using non-neuronal systems and may not apply to neurons, which have their own bioenergetic needs and present a unique, extensive neurite network. Moreover, the basis of the selective neuronal vulnerability, which primarily affects large sensory neurons in the dorsal root ganglia, large principal neurons in the dentate nuclei of the cerebellum, and pyramidal neurons in the cerebral cortex, remains elusive. In order to identify potential misbeliefs in the field and highlight controversies, we reviewed current knowledge on frataxin expression in different tissues, discussed the molecular function of frataxin, and the consequences of its deficiency for mitochondria structural and functional properties, with a focus on the nervous system.

摘要

弗里德里希共济失调是一种线粒体疾病家族中的多系统遗传性疾病,其特征是必需的线粒体蛋白 frataxin 水平降低。基于临床证据,外周神经系统受到早期影响,神经元功能向中枢神经系统进展,其他器官(如心脏和胰腺)受到后期影响。然而,人们对神经系统中 frataxin 耗竭改变的线粒体功能的具体方面关注甚少。多年来,弗里德里希共济失调中线粒体功能障碍的公认观点源于使用非神经元系统的研究,可能不适用于具有自身生物能量需求并具有独特而广泛的神经突网络的神经元。此外,选择性神经元易损性的基础仍不清楚,这种易损性主要影响背根神经节中的大型感觉神经元、小脑齿状核中的大型主神经元以及大脑皮层中的锥体神经元。为了确定该领域中的潜在误解并突出争议,我们回顾了不同组织中 frataxin 表达的现有知识,讨论了 frataxin 的分子功能及其缺乏对线粒体结构和功能特性的影响,重点是神经系统。

相似文献

1
Mitochondrial dysfunction in neurons in Friedreich's ataxia.弗里德里希共济失调症中神经元的线粒体功能障碍。
Mol Cell Neurosci. 2020 Jan;102:103419. doi: 10.1016/j.mcn.2019.103419. Epub 2019 Nov 23.
2
Mitochondrial pathophysiology in Friedreich's ataxia.弗里德里希共济失调症中的线粒体病理生理学。
J Neurochem. 2013 Aug;126 Suppl 1:53-64. doi: 10.1111/jnc.12303.
3
Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich's ataxia.线粒体外的小鼠 frataxin 及其对弗里德里希共济失调症小鼠模型的影响。
Sci Rep. 2020 Sep 25;10(1):15788. doi: 10.1038/s41598-020-72884-w.
4
'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.线粒体能量失衡和脂质过氧化导致弗里德赖希共济失调中的细胞死亡。
Cell Death Dis. 2016 May 26;7(5):e2237. doi: 10.1038/cddis.2016.111.
5
Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.修复共济失调蛋白:“消除”弗里德赖希共济失调的代谢缺陷
Br J Pharmacol. 2014 Apr;171(8):2174-90. doi: 10.1111/bph.12470.
6
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.药物重定位筛选发现依曲韦林可能成为治疗弗里德里希共济失调的一种疗法。
Mov Disord. 2019 Mar;34(3):323-334. doi: 10.1002/mds.27604. Epub 2019 Jan 9.
7
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.过氧化物酶体增殖物激活受体 γ 激动剂利拉列酮改善弗里德里希共济失调细胞和动物模型中的 frataxin 缺失损伤。
Neurobiol Dis. 2021 Jan;148:105162. doi: 10.1016/j.nbd.2020.105162. Epub 2020 Nov 7.
8
Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.弗里德里希共济失调中的神经退行性变:从缺陷的 frataxin 到氧化应激。
Oxid Med Cell Longev. 2013;2013:487534. doi: 10.1155/2013/487534. Epub 2013 Jul 9.
9
Friedreich's ataxia.弗里德赖希共济失调
Pediatr Neurol. 2003 May;28(5):335-41. doi: 10.1016/s0887-8994(03)00004-3.
10
Friedreich's ataxia: clinical aspects and pathogenesis.弗里德赖希共济失调:临床特征与发病机制
Semin Neurol. 1999;19(3):311-21. doi: 10.1055/s-2008-1040847.

引用本文的文献

1
Clinical and cognitive assessment in Friedreich ataxia clinical trials: a review.弗里德赖希共济失调临床试验中的临床与认知评估:综述
Front Neurol. 2025 May 22;16:1558493. doi: 10.3389/fneur.2025.1558493. eCollection 2025.
2
Calcium bridges built by mitochondria-associated endoplasmic reticulum membranes: potential targets for neural repair in neurological diseases.由线粒体相关内质网膜构建的钙桥:神经疾病神经修复的潜在靶点。
Neural Regen Res. 2025 Dec 1;20(12):3349-3369. doi: 10.4103/NRR.NRR-D-24-00630. Epub 2024 Nov 13.
3
Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis.
衰老、ROS 和细胞衰老:肝纤维化进展中的三部曲。
Biogerontology. 2024 Nov 15;26(1):10. doi: 10.1007/s10522-024-10153-3.
4
Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases.线粒体未折叠蛋白反应(mtUPR)介导的线粒体质量控制在衰老和神经退行性疾病中的作用。
Biomolecules. 2023 Dec 13;13(12):1789. doi: 10.3390/biom13121789.
5
Mitochondrial impairment, decreased sirtuin activity and protein acetylation in dorsal root ganglia in Friedreich Ataxia models.弗里德里希共济失调模型中背根神经节线粒体损伤、沉默调节蛋白活性降低和蛋白质乙酰化。
Cell Mol Life Sci. 2023 Dec 21;81(1):12. doi: 10.1007/s00018-023-05064-4.
6
Research Models to Study Ferroptosis's Impact in Neurodegenerative Diseases.研究铁死亡对神经退行性疾病影响的研究模型。
Pharmaceutics. 2023 Apr 29;15(5):1369. doi: 10.3390/pharmaceutics15051369.
7
Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases.血液 RNA 转录本揭示了阿尔茨海默病和其他神经退行性疾病中基本细胞过程的相似和不同改变。
Alzheimers Dement. 2023 Jun;19(6):2618-2632. doi: 10.1002/alz.12880. Epub 2022 Dec 21.
8
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES).来立普唑治疗弗里德赖希共济失调患者的疗效与安全性:一项2期双盲随机对照试验(FRAMES)
Neurol Genet. 2022 Nov 1;8(6):e200034. doi: 10.1212/NXG.0000000000200034. eCollection 2022 Dec.
9
Integration of the Connectivity Map and Pathway Analysis to Predict Plant Extract's Medicinal Properties-The Study Case of L.整合连通性图谱与通路分析以预测植物提取物的药用特性——以L.为例的研究
Plants (Basel). 2022 Aug 24;11(17):2195. doi: 10.3390/plants11172195.
10
Cerebral Iron Deposition in Neurodegeneration.脑铁沉积与神经变性疾病。
Biomolecules. 2022 May 17;12(5):714. doi: 10.3390/biom12050714.